Government support for the development of Covid-19 vaccines took two different forms. Some firms accepted grants (a.k.a, direct monetary support) for vaccine development and testing. As a condition of the grant, the government has options to purchase a first and specific number of vaccine doses. Other firms chose not to accept grants. Instead they negotiated advanced-purchase agreement to support pre-approval manufacturing of vaccines. The purchase agreement stipulates that payment will be made upon delivery of the pre-specified number of doses. In the case of advanced purchase agreements, who bears the cost of a failure?
Government support for the development of Covid-19 vaccines took two different forms. Some firms accepted grants (a.k.a, direct monetary support) for vaccine development and testing. As a condition of the grant, the government has options to purchase a first and specific number of vaccine doses. Other firms chose not to accept grants. Instead they negotiated advanced-purchase agreement to support pre-approval manufacturing of vaccines. The purchase agreement stipulates that payment will be made upon delivery of the pre-specified number of doses.
In the case of advanced purchase agreements, who bears the cost of a failure?
Purchase agreement of advanced situation would involve risk for the purchasing governments.
Because the payment has to made immediately,and if vaccine doses are not successful,those governments will go into loss.
Trending now
This is a popular solution!
Step by step
Solved in 2 steps
